A Novel Vaccine for the Treatment of MUC1-expressing Tumor Malignancies
Clinical trial NCT00162500 · WITHDRAWN
Trial details
- NCT number
- NCT00162500
- Sponsor
- Hadassah Medical Organization
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.